Log in to save to my catalogue

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance T...

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance T...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_cid_ciy547

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men

About this item

Full title

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men

Publisher

US: Oxford University Press

Journal title

Clinical infectious diseases, 2019-02, Vol.68 (4), p.569-576

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

We treated 122 human immunodeficiency virus/hepatitis C virus-infected individuals with grazoprevir/elbasvir ± ribavirin for 12-16 weeks and achieved a sustained virological response rate of 99%. In genotype 1a infected individuals, treatment duration was guided by presence of baseline resistance-associated substitutions.
Abstract
Background<...

Alternative Titles

Full title

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1093_cid_ciy547

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_cid_ciy547

Other Identifiers

ISSN

1058-4838

E-ISSN

1537-6591

DOI

10.1093/cid/ciy547

How to access this item